A Phase I, Single-center, Single-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral AZD1979 After Single-ascending Doses in Healthy Male Volunteers

Trial Profile

A Phase I, Single-center, Single-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral AZD1979 After Single-ascending Doses in Healthy Male Volunteers

Discontinued
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2014

At a glance

  • Drugs AZD 1979 (Primary)
  • Indications Unspecified
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 28 Jul 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 02 Apr 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 05 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top